mp.weixin.qq.com·· 4 hours agoPickScore65
NMPA Approves Ruxolitinib Phosphate Cream, China's First Topical JAK Inhibitor for Vitiligo
In brief
On January 30, 2026, the NMPA approved ruxolitinib phosphate cream (brand name Bailand/Ruvtos, English name uncertain) for marketing in China for vitiligo. The source describes it as China's first topical JAK inhibitor for vitiligo but provides no mechanism of action, developer, or clinical data.
Why it matters
The material gives the NMPA approval date, brand name, and vitiligo indication, allowing verification of this topical JAK inhibitor's basic approval details.
Source: mp.weixin.qq.com · mp.weixin.qq.com